Risk explainer
How Deadly Is Hantavirus? Mortality, Fatality, and Survival
The hantavirus death rate depends on which number you mean: CDC reports about 36-38% case fatality for hantavirus pulmonary syndrome (HPS), WHO reports up to 50% (commonly 20-40%) for HCPS in the Americas, and the MV Hondius Andes virus cluster currently shows a provisional figure near 23%. A 38% fatality rate also means roughly 62% of diagnosed people survive. This page explains why the three numbers differ and what improves survival.
Quick Facts
HPS fatality
38%
CDC figure for people who develop respiratory symptoms
MV Hondius
3
Deaths in the current tracker dataset
Confirmed
11
Confirmed Andes virus infections in this cluster
Survival
~62%
Implied by a ~38% HPS case fatality rate
Why You See 38%, 50%, and 23% for Hantavirus
Three Different Numbers, Three Different Questions
If you search the hantavirus death rate you will find several numbers. They are not contradictions — they answer different questions.
| Number | Source | What it actually measures |
|---|---|---|
| ~36-38% | CDC | US HPS (mainly Sin Nombre virus) among people who develop respiratory symptoms |
| Up to 50% (commonly 20-40%) | WHO | HCPS across the Americas, including Andes virus, over many outbreaks |
| ~23% | This tracker | MV Hondius cluster only: 3 deaths ÷ 13 reported cases, provisional and still changing |
So the "right" number depends on whether you mean US HPS (CDC), all-Americas HCPS (WHO), or this specific cruise-ship cluster (provisional).
Hantavirus Death Rate by Virus and Syndrome
Reported Case Fatality Ranges
"How deadly is hantavirus" has no single answer — it depends on the virus and syndrome. The table below shows reported case fatality ranges. Always confirm against official sources before quoting a number.
| Virus / syndrome | Reported case fatality | Region |
|---|---|---|
| HPS — Sin Nombre virus | ~38% | North America |
| HPS — Andes virus | High; reported ~25-40% | South America |
| HFRS — Hantaan virus (severe) | ~5-15% | East Asia |
| HFRS — Puumala virus (mild) | Below ~1% | Northern Europe |
The MV Hondius cluster involves Andes virus, the South American strain in the higher-fatality HPS group.
Death Rate vs Survival Rate
A 38% Death Rate Means About 62% Survive
Case fatality rate (CFR) and survival rate are two sides of the same statistic. If the CFR for HPS is about 38%, then roughly 62% of diagnosed people survive. People searching "how deadly is hantavirus" often want the survival side of that number.
Two cautions. First, CFR counts people sick enough to be diagnosed, so it does not describe mild or undetected infections. Second, survival is not fixed: it improves substantially with early recognition and intensive supportive care, and it varies by virus type — Andes and Sin Nombre HPS are more severe than mild HFRS.
Why Hantavirus Fatality Numbers Differ
Compare Like With Like
Hantavirus is a virus family, not one identical illness. HPS in the Americas, HFRS in Europe and Asia, Andes virus, Sin Nombre virus, Seoul virus, and Puumala virus do not all have the same severity profile.
A headline death rate should always specify the syndrome, case definition, country, and time period. For MV Hondius, the tracker separates current deaths from general HPS fatality statistics.
MV Hondius Death Count
Current Outbreak Context
The current dataset reports 3 deaths, 11 confirmed infections, 2 probable cases, and 0 inconclusive case in the MV Hondius-linked cluster.
That is a provisional case fatality ratio of about 23% (3 deaths ÷ 13 reported cases). Outbreak fatality ratios change as more cases are confirmed or as patients recover, so this is provisional and not a final mortality rate.
Because additional cases can appear during the monitoring window, this count should be checked against the latest WHO/ECDC/CDC updates before reuse.
What Improves Survival
Speed and Supportive Care
Survival depends on how fast the illness is recognized and whether respiratory and circulatory support are available before severe complications advance.
For an exposed person, the practical takeaway is simple: do not wait through worsening cough, shortness of breath, chest tightness, or rapid decline.
Frequently Asked Questions
Sources
- WHO Director-General's opening remarks at the media briefing on hantavirus – 12 May 2026World Health Organization · 2026-05-12
- Hantavirus fact sheetWorld Health Organization · 2026-05-06
- Factsheet on orthohantavirus infectionsEuropean Centre for Disease Prevention and Control · 2026-05-06
- About HantavirusCenters for Disease Control and Prevention · 2024-05-13
- About Andes VirusCenters for Disease Control and Prevention · 2026-05-07